Ampyra first, ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	1

6. Parkinson disease

---

Clinical trials : 2,307 /  Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01491022 (ClinicalTrials.gov)	July 2012	8/12/2011	A Randomized Trial to Evaluate Ampyra for Gait Impairment in Parkinson's Disease	A Randomized Trial to Evaluate Ampyra for Gait Impairment in Parkinson's Disease	Parkinson's Disease	Drug: Ampyra first, then Placebo;Drug: placebo first, then Ampyra	University of Miami	Acorda Therapeutics	Completed	45 Years	80 Years	All	22	Phase 1/Phase 2	United States